Examiner Lorraine Spector

Appears inactive Last observed office action: October 2016 (113 months ago).

Examiner Lorraine Spector appears to be about average relative to their peer examiners. Their lifetime grant ratio is 36.0%, they average 1.75 office actions per granted patent, and their rejection profile is dominated by §103.

Difficulty vs AU Very Hard

Difficulty vs Group About Average

Difficulty vs TC About Average

Difficulty vs USPTO About Average

Average OA / Grant 1.75

Export

Word PDF

Create account to export.

Examiner Details

Observed Examiner Years: 10 years (2007-2016)
Tech Center: 1600 - Biotechnology and Organic
Group: 1640 - Immunology

Metrics

Applications Evaluated: 89
Granted Applications: 32
Non-Granted Applications: 57
Avg OA / Grant: 1.75
Last OA Observed: October 2016 (113 months ago)
Art Units Seen: 1647
Work Groups Seen: 1640 - Immunology

Context Comparison

Scope	Examiners	Lifetime Grant Ratio	Avg OA / Grant
This Examiner	1	36.0%	1.75
Art Unit	36	42.6%	1.60
Group	223	44.8%	1.94
Tech Center	1,349	39.5%	2.02
USPTO	16,116	54.8%	1.98

Grant Timeline

Shaded region marks the last two observed years, where grant outcomes may lag due to recency.

Year	Applications	Granted	Grant Rate
2007	4	0	0.0%
2008	18	5	27.8%
2009	22	8	36.4%
2010	24	12	50.0%
2011	9	5	55.6%
No observed data for 2012-2014.
2015	1	0	0.0%
2016	11	2	18.2%
No observed data after 2016; examiner may have gone inactive or moved out of examining work.

32 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA #	Office Actions	§ 101 Percentage	§ 102 Percentage	§ 103 Percentage	§ 112 Percentage
1	89	0.0%	24.7%	46.1%	18.0%
2	34	5.9%	14.7%	52.9%	26.5%
3	12	0.0%	16.7%	66.7%	16.7%
4	4	0.0%	0.0%	100.0%	0.0%
5	2	0.0%	0.0%	100.0%	0.0%

§ 101 Yearly Trend

2014: Alice

0.0%

2007

0.0%

2008

0.0%

2009

3.3%

2010

0.0%

2011

0.0%

2013

50.0%

2014

0.0%

2015

0.0%

2016

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.